The steady rise in popularity of gene therapies and other biologics is the underlying reason for the growing importance of aseptic manufacturing processes in the biopharmaceutical industry.
Brian Greven
Advertisement
Brian Greven is senior director of Quality & Validation at Matica Bio.
Articles by Brian Greven
Advertisement
Latest Updated Articles
Advertisement
Advertisement